DNA base editors, typically comprising editing enzymes fused to the N-terminus of nCas9, display off-target effects on DNA and/or RNA, which have remained a obstacle to their clinical applications. Off-target edits are typically countered via rationally designed point mutations, but the approach is tedious and not always effective. Here, we report that the off-target effects of both A>G and C>T editors can be dramatically reduced without compromising the on-target editing simply by inserting the editing enzyme into the middle of nCas9 at tolerant sites identified using a transposon-based genetic screen. Furthermore, employing this Cas-embedding method, we have created a highly specific editor capable of efficient C>T editing at methylated and GC-rich sequences.